Robert te Poele

2.7k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Robert te Poele is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert te Poele has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Robert te Poele's work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (3 papers) and Microtubule and mitosis dynamics (3 papers). Robert te Poele is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (3 papers) and Microtubule and mitosis dynamics (3 papers). Robert te Poele collaborates with scholars based in United Kingdom, United States and Germany. Robert te Poele's co-authors include Andrei L. Okorokov, Simon P. Joel, Paul Workman, Lesley Jardine, Jeffrey L. Cummings, Paul A. Clarke, Ian Giddings, Richard Wooster, Colin S. Cooper and Sandra E. Edwards and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Robert te Poele

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA damage is able to induce senescence in tumor cells in vitro and in vivo.

2002 537 citations Robert te Poele, Andrei L. Okorokov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert te Poele United Kingdom	20	1.1k	451	367	292	206	33	1.7k
Zhihu Ding United States	14	2.1k 1.8×	452 1.0×	375 1.0×	516 1.8×	160 0.8×	21	2.7k
Véronique Gire France	20	1.2k 1.0×	607 1.3×	578 1.6×	210 0.7×	172 0.8×	31	1.8k
Amee J. George Australia	16	1.2k 1.1×	308 0.7×	377 1.0×	195 0.7×	87 0.4×	22	1.9k
Michael K. Connor Canada	19	1.2k 1.1×	575 1.3×	299 0.8×	182 0.6×	227 1.1×	31	1.6k
Dongmei Zuo Canada	27	1.6k 1.4×	385 0.9×	197 0.5×	329 1.1×	311 1.5×	54	2.2k
Chitra Venugopal Canada	21	1.1k 0.9×	623 1.4×	242 0.7×	483 1.7×	123 0.6×	94	2.0k
Gary Bellinger United States	11	1.4k 1.2×	360 0.8×	208 0.6×	749 2.6×	201 1.0×	13	1.9k
Ariel F. Castro United States	20	1.3k 1.1×	364 0.8×	206 0.6×	135 0.5×	243 1.2×	46	1.7k
Eugenia M. Yazlovitskaya United States	25	1.2k 1.1×	423 0.9×	111 0.3×	278 1.0×	166 0.8×	48	1.9k
Péter Ács United States	26	969 0.8×	451 1.0×	326 0.9×	282 1.0×	136 0.7×	42	2.1k

Countries citing papers authored by Robert te Poele

Since Specialization

Citations

This map shows the geographic impact of Robert te Poele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert te Poele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert te Poele more than expected).

Fields of papers citing papers by Robert te Poele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert te Poele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert te Poele. The network helps show where Robert te Poele may publish in the future.

Co-authorship network of co-authors of Robert te Poele

This figure shows the co-authorship network connecting the top 25 collaborators of Robert te Poele. A scholar is included among the top collaborators of Robert te Poele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert te Poele. Robert te Poele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newman, J.A., H. Aitkenhead, Robert te Poele, et al.. (2025). Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy. Nature Communications. 16(1). 1596–1596. 2 indexed citations

Poele, Robert te, et al.. (2023). 8P NXP800 versus cisplatin in ARID1a-mutated ovarian clear cell carcinoma xenograft models. ESMO Open. 8(1). 100862–100862. 3 indexed citations

Workman, Paul, Paul A. Clarke, Robert te Poele, et al.. (2022). Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor. European Journal of Cancer. 174. S35–S35. 4 indexed citations

Platt, Georgina, S. Elaine Barrie, Georgia Zoumpoulidou, et al.. (2012). Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling. PLoS ONE. 7(1). e28568–e28568. 86 indexed citations

Beloueche‐Babari, Mounia, Helen Troy, Robert te Poele, et al.. (2011). Histone Deacetylase Inhibition Increases Levels of Choline Kinase α and Phosphocholine Facilitating Noninvasive Imaging in Human Cancers. Cancer Research. 72(4). 990–1000. 23 indexed citations

Rao, Sheela, David Cunningham, Robert te Poele, et al.. (2011). Correlation of Overall Survival With Gene Expression Profiles in a Prospective Study of Resectable Esophageal Cancer. Clinical Colorectal Cancer. 10(1). 48–56. 11 indexed citations

Guillard, Sandrine, Paul A. Clarke, Robert te Poele, et al.. (2009). Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma. Cell Cycle. 8(3). 443–453. 57 indexed citations

Whittaker, Steven R., Robert te Poele, Florence Chan, et al.. (2007). The Cyclin-Dependent Kinase Inhibitor Seliciclib (R-roscovitine; CYC202) Decreases the Expression of Mitotic Control Genes and Prevents Entry into Mitosis. Cell Cycle. 6(24). 3114–3131. 54 indexed citations

Bradshaw, Tracey D., Erica L. Stone, Valentina Trapani, et al.. (2007). Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines. Breast Cancer Research and Treatment. 110(1). 57–68. 30 indexed citations

10.

Hockley, Sarah L., Volker M. Arlt, Daniel Brewer, et al.. (2007). AHR- and DNA-Damage-Mediated Gene Expression Responses Induced by Benzo(a)pyrene in Human Cell Lines. Chemical Research in Toxicology. 20(12). 1797–1810. 81 indexed citations

11.

Chan, Florence, Chongbo Sun, Meg Perumal, et al.. (2007). Characterization of CCT129202, a novel Aurora kinase inhibitor and in vivo quantification of biological activity. 6. 1 indexed citations

12.

Feber, Andrew, Sandra E. Edwards, Robert te Poele, et al.. (2006). Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 26(7). 1028–1037. 102 indexed citations

13.

Knowles, Helen J., Robert te Poele, Paul Workman, & Adrian L. Harris. (2006). Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochemical Pharmacology. 71(5). 646–656. 79 indexed citations

14.

Edwards, Sandra E., Colin Campbell, Penny Flohr, et al.. (2004). Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. British Journal of Cancer. 92(2). 376–381. 81 indexed citations

15.

Clarke, Paul A., Robert te Poele, & Paul Workman. (2004). Gene expression microarray technologies in the development of new therapeutic agents. European Journal of Cancer. 40(17). 2560–2591. 58 indexed citations

16.

Kote‐Jarai, Zsofia, Richard D. Williams, Ian Giddings, et al.. (2004). Gene Expression Profiling after Radiation-Induced DNA Damage Is Strongly Predictive ofBRCA1Mutation Carrier Status. Clinical Cancer Research. 10(3). 958–963. 33 indexed citations

17.

Clarke, Paul A., Robert te Poele, Richard Wooster, & Paul Workman. (2001). Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin.. Biochemical Pharmacology. 62(10). 1311–1336. 138 indexed citations

18.

Poele, Robert te, Andrei L. Okorokov, & Simon P. Joel. (1999). RNA synthesis block by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene. 18(42). 5765–5772. 50 indexed citations

19.

Poele, Robert te, et al.. (1999). Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines. British Journal of Cancer. 81(8). 1285–1293. 34 indexed citations

20.

Okorokov, Andrei L., Kostya I. Panov, Robert te Poele, et al.. (1995). An Efficient System for Active Bovine Pancreatic Ribonuclease Expression in Escherichia coli. Protein Expression and Purification. 6(4). 472–480. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact